Genmab — September 2018
-
-
En fin artikel om bispecifikke antistoffer - mange gode svar på hvordan, hvorfor
etc. https://www.sciencedirect.com/science/article/pii/S135964461500077X -
Primary effusion lymphoma is a rare type of non-Hodgkin’s lymphoma (…) the patient received off-label, single-agent, weekly daratumumab (…)CT imaging at approximately 3 months from the start of therapy showed no evidence of lymphoma. New England Journal of Medicine, august 16, 2018 (Daratumumab in Primary Effusion Lymphoma).
-
-
@Pensionisten Puds lige brillerne - "Bank of America Merrill Lynch Global Healthcare Conference 2018, London, UK" står i allerførste li
nje af "Events & Presentations"
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind